Treatment of mastitis during lactation

Irish Veterinary Journal

Volumn 62, Issue 4, 2009, Pages 40-44

  Pyorala S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

antibiotic; antimicrobial; bovine; intramammary; lactation; mastitis; systemic; therapy; treatment

Indexed keywords

EID: 84861802337     PISSN: 03680762     EISSN: 20460481     Source Type: Journal    
DOI: 10.1186/2046-0481-62-S4-S40     Document Type: Article

References (60)

1. Anonymous: Use of antimicrobial agents in animals. Report of the working group on antimicrobial agents. Ministry of Agriculture and Forestry in Finland. MAFF Publications 9. [Online] Helsinki, MAFF. 2003, [Accessed February 20 2006], [ http://wwwb.mmm.fi/julkaisut/tyoryhmamuistiot/2003/tr2003-9.pdf ]
2. Barkema H, Schukken YH, Zadoks RN: Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci. 2006, 89: 1877-1895. 10.3168/jds.S0022-0302(06)72256-1.
3. Cockcroft P, Holmes M: Evidence-based veterinary medicine. 2003, Oxford UK, Blackwell Publishing, 1
4. Deluyker HA, Van Oye SN, Boucher JF: Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J Dairy Sci. 2005, 88: 604-614. 10.3168/jds.S0022-0302(05)72724-7.
5. Dosogne H, Meyer E, Sturk A, et al: Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis. Inflamm Res. 2002, 51: 201-205. 10.1007/PL00000293.
6. Duenas MI, Paape MJ, Wettemann RP, et al: Incidence of mastitis in beef cows after intramuscular administration of oxytetracycline. J Anim Sci. 2001, 79: 1996-2005.
7. Ehinger AM, Kietzmann M: Tissue distribution of oxacillin and ampicillin in the isolated perfused bovine udder. J Vet Med A. 2000, 47: 157-168. 10.1046/j.1439-0442.2000.00272.x.
8. Ehinger AM, Kietzmann M: Tissue distribution of benzylpenicillin after intramammary administration in the isolated perfused bovine udder. J vet Pharm Therap. 2000, 23: 303-310. 10.1046/j.1365-2885.2000.00274.x.
9. Erskine RJ: Antibacterial therapy of clinical mastitis - part I. Drug selection. Part II Administration. North Am Vet Conf, Proc. 2003, 13-16.
10. Erskine RJ, Barlett PC: Intramuscular administration of ceftiofur sodium versus intramammary infusion of penicillin/novobiocin for treatment of Streptococcus agalactiae mastitis in dairy cows. J Am Vet Med Assoc. 1996, 208: 258-260.
11. Erskine RJ, Barlett PC, VanLente JL, et al: Efficacy of systemic ceftiofur for severe clinical mastitis in dairy cattle. J Dairy Sci. 2002, 85: 2571-2575. 10.3168/jds.S0022-0302(02)74340-3.
12. Erskine RJ, Wilson RC, Tyler JW, et al: Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental Escherichia coli - induced mastitis. Am J Vet Res. 1995, 56: 481-486.
13. Fang W, Pyörälä S: Mastitis causing Escherichia coli: serum sensitivity and susceptibility to selected antibacterials in milk. J Dairy Sci. 1996, 79: 76-82. 10.3168/jds.S0022-0302(96)76336-1.
14. Finnish veterinary antimicrobial resistance monitoring and comsumption of antimicrobial agents. Finnish Food Safety Authority Evira [Internet] Helsinki, Multiprint. 2007, [Accessed January 31 2009], [ http://www.palvelu.fi/evi/files/55-519-523.pdf ]
15. Franklin A, Holmberg O, Horn af Rantzien M, et al: Effect of procaine benzylpenicillin alone or in combination with dihydrostreptomycin on udder pathogens in vitro and in experimentally infected bovine udders. Am J Vet Res. 1984, 45: 1398-1402.
16. Franklin A, Horn af Rantzien M, Obel N, et al: Concentrations of penicillin, streptomycin, and spiramycin in bovine udder tissue liquids. Am J Vet Res. 1986, 47: 804-807.
17. Grave T, Greko C, et al: The usage of veterinary antibacterial drugs for mastitis in cattle in Norway and Sweden during 1990-1997. Prev Vet Med. 1999, 42: 45-55. 10.1016/S0167-5877(99)00057-4.
18. Hallén Sandgren C, Persson Waller K, Emanuelson U: Therapeutic effects of systemic or intramammary antimicrobial treatment of bovine subclinical mastitis during lactation. Vet J. 2008, 175: 108-117. 10.1016/j.tvjl.2006.12.005.
19. Haveri M, Roslöf A, Rantala L, et al: Virulence genes in bovine Staphylococcus aureus mastitis of different clinical characteristics and outcome. J Appl Microb. 2005, 103: 993-1000. 10.1111/j.1365-2672.2007.03356.x.
20. Hendriksen RS, Mevius DJ, Schroeter A, et al: Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002-2004. Acta Vet Scand. 2008, 50: 28-10.1186/1751-0147-50-28. [ http://www.actavetscand.com/content/50/1/28 ]
21. Jarp J, Bugge HP, Larsen S: Clinical trial of three therapeutic regimens for bovine mastitis. Vet Rec. 1989, 124: 630-634. 10.1136/vr.124.24.630.
22. Jones GF, Ward GE: Evaluation of systemic administration of gentamicin for treatment of coliform mastitis in cows. J Am Vet Med Assoc. 1990, 197: 731-735.
23. Kaartinen L, Löhönen K, Wiese B, et al: Pharmacokinetics of sulphadiazine-trimethoprim in lactating dairy cows. Acta vet Scand. 1999, 40: 271-278.
24. Kehrli M, Harp J: Immunity in the mammary gland. Vet Clinics North Am - Food Animal Practice. 2001, 17: 495-516.
25. Lehtolainen T, Shpigel N, Pohjanvirta T, et al: In vitro antimicrobial susceptibility of Escherichia coli isolates originating from clinical mastitis in Finland and Israel. J Dairy Sci. 2003, 86: 3927-3932. 10.3168/jds.S0022-0302(03)74001-6.
26. Lents CA, Wettemann RP, Paape MJ, et al: Efficacy of intramuscular treatment of beef cows with oxytetracycline to reduce mastitis and to increase calf growth. J Anim Sci. 2002, 80: 1405-1412.
27. Loch IM, Glenn K, Zadoks RN: Macrolide and lincosamide resistance genes of environmental streptococci from bovine milk. Vet Microb. 2005, 111: 133-138. 10.1016/j.vetmic.2005.09.001.
28. Louhi M, Inkinen K, Myllys V, et al: Relevance of sensitivity testings (MIC) of S. aureus to predict the antibacterial action in milk. J Vet Med B. 1992, 39: 253-262. 10.1111/j.1439-0450.1992.tb01166.x.
29. McDermott MP, Erb HN, Natzke RP, et al: Cost benefit analysis of lactation therapy with somatic cell counts as indications for treatment. J Dairy Sci. 1983, 66: 1198-1203. 10.3168/jds.S0022-0302(83)81919-5.
30. McDougall S, Agnew KE, Cursons R, et al: Parenteral treatment of clinical mastitis with tylosin base or penethamate hydriodide in dairy cattle. J Dairy Sci. 2007, 90: 779-789. 10.3168/jds.S0022-0302(07)71562-X.
31. Mitchell JM, Griffiths MW, McEwen SA, et al: Antimicrobial drug residues in milk and meat: causes, concerns, prevalence, regulations, tests and test performance. J Food Protect. 1998, 61: 742-756.
32. Moretain JP, Boisseau J: Excretion of penicillins and cephalexin in bovine milk following intramammary administration. Food Add Contamin. 1989, 6: 79-90.
33. OIE: Guidelines on the responsible and prudent use of antimicrobial agents in veterinary medicine. 2008, [Accessed September 25 2008], [ http://www.oie.int/eng/normes/Mcode/en-chapitre-1.6.7.htm ]
34. Oliver SP, Almeida RA, Gillespie BE, et al: Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle. J Dairy Sci. 2004, 87: 3322-3329. 10.3168/jds.S0022-0302(04)73468-2.
35. Olsen JE, Christensen H, Aarestrup FM: Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci. J Antimicrob Chemother. 2006, 57: 450-460. 10.1093/jac/dki492.
36. Owens WE, Nickerson SC, Ray CH: Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation. J Dairy Sci. 1999, 82: 645-647. 10.3168/jds.S0022-0302(99)75279-3.
37. Passantino A: Ethical aspects for veterinarians regarding antimicrobial drug use in Italy. Int J Antimicrob Agents. 2007, 29: 240-244. 10.1016/j.ijantimicag.2006.09.023.
38. Pitkälä A, Haveri M, Pyörälä S, et al: Bovine mastitis in Finland 2001 - prevalence, distribution of bacteria and antimicrobial resistance. J Dairy Sci. 2004, 87: 2433-2441. 10.3168/jds.S0022-0302(04)73366-4.
39. Poutrel B, Stegemann MR, Roy O, et al: Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. Journal of Dairy Research. 2008, 75: 310-318. 10.1017/S0022029908003348.
40. Pyörälä S, Kaartinen L, Käck H, et al: Efficacy of Two Therapy Regimes for Treatment of Experimentally Induced Escherichia coli Mastitis in the Bovine. J Dairy Sci. 1994, 77: 453-461. 10.3168/jds.S0022-0302(94)76973-3.
41. Pyörälä S, Manner E, Kesti E, et al: Local tissue damage in cows after intramuscular injections of eight different antimicrobial agents. Brief communication. Acta vet Scand. 1994, 35: 107-110.
42. Pyörälä S, Pyörälä E: Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases: (1989-1995). J Am Vet Med Assoc. 1998, 212: 407-412.
43. Rantala M, Kaartinen L, Välimäki E, et al: Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J vet Pharmacol Therap. 2002, 25: 251-258. 10.1046/j.1365-2885.2002.00411.x.
44. Raymond MJ, Wohlre RD, Call DR: Assessment and Promotion of Judicious Antibiotic Use on Dairy Farms in Washington State. J Dairy Sci. 2006, 89: 3228-3240. 10.3168/jds.S0022-0302(06)72598-X.
45. Sanders P, Moulin G, Guillot P, et al: Pharmacokinetics of spiramycin after intravenous, intramuscular and subcutaneous administration in lactating cows. J vet Pharmacol Therap. 1992, 15: 53-61. 10.1111/j.1365-2885.1992.tb00986.x.
46. Sawant AA, Sordillo LM, Jayarao BM: A survey on antibiotic usage in dairy herds in Pennsylvania. J Dairy Sci. 2005, 88: 2991-2999. 10.3168/jds.S0022-0302(05)72979-9.
47. Sawant AA, Gillespie BE, Oliver SP: Antimicrobial susceptibility of coagulase-negative Staphylococcus species isolated from bovine milk. Vet Microb. 2009, 134: 73-81. 10.1016/j.vetmic.2008.09.006.
48. Shephard RW, Malmo J, Pfeiffer DU: A clinical trial to evaluate the effectiveness of antibiotic treatment of lactating cows with high somatic cell counts in their milk. Austr Vet J. 2000, 78: 763-768. 10.1111/j.1751-0813.2000.tb10448.x.
49. Shpigel NY, Levin D, Winkler M, et al: Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. J Dairy Sci. 1997, 80: 318-323. 10.3168/jds.S0022-0302(97)75941-1.
50. Sol J, Sampimon OC, Barkema HW, et al: Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J Dairy Sci. 2000, 83: 278-284. 10.3168/jds.S0022-0302(00)74875-2.
51. Taponen S, Dredge K, Henriksson B, et al: Efficacy of intramammary treatment with procaine penicillin G vs. procaine penicillin plus neomycin in bovine clinical mastitis caused by penicillin-susceptible, gram-positive bacteria - a double blind field study. J vet Pharm Therap. 2002, 26: 193-198. 10.1046/j.1365-2885.2003.00473.x.
52. Taponen S, Jantunen A, Pyörälä E, et al: Efficacy of targeted five day parenteral and intramammary treatment of clinical Staphylococcus aureus mastitis caused by penicillin-susceptible or penicillin-resistant bacterial isolate. Acta vet Scand. 2003, 44: 53-62. 10.1186/1751-0147-44-53.
53. Ullberg S, Hansson E, Funke H: Distribution of penicillin in mastitic udders following intramammary injection - an autoradiographic study. Am J Vet Res. 1958, 19: 84-92.
54. Waage S: Comparison of two regimens for the treatment of clinical bovine mastitis caused by bacteria sensitive to penicillin. Vet Rec. 1997, 141: 616-620.
55. Wagner S, Erskine R: Antimicrobial drug use in bovine mastitis. Antimicrobial Therapy in Veterinary Medicine. Edited by: Giguère S, Prescott JD, Baggot RD, et al. 2006, Oxford, Blackwell, 4
56. Wenz JR, Barrington GM, Garry FB, et al: Bacteraemia associated with naturally occurring acute coliform mastitis in dairy cows. J Am Vet Med Assoc. 2001, 219: 976-981. 10.2460/javma.2001.219.976.
57. Whittem T, Hanlon D: Dihydrostreptomycin or streptomycin in combination with penicillin in dairy cattle therapeutics: a review and re-analysis of published data, Part 1: Clinical pharmacology. New Zealand Vet J. 1997, 45: 178-184. 10.1080/00480169.1997.36022.
58. Wilson DJ, Gonzalez RN, Case KL, et al: Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. J Dairy Sci. 1999, 82: 1664-1670. 10.3168/jds.S0022-0302(99)75395-6.
59. Ziv G: Drug selection and use in mastitis: systemic vs. local therapy. J Am Vet Med Assoc. 1980, 176: 1109-1115.
60. Ziv G, Storper M: Intramuscular treatment of subclinical staphylococcal mastitis in lactating cows with penicillin G, methicillin and their esters. J vet Pharmacol Therap. 1985, 8: 276-283. 10.1111/j.1365-2885.1985.tb00957.x.